Clinical Trial Update: Avelumab With Valproic Acid in Virus-associated Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the PD-L1 inhibitor avelumab in combination with valproic acid for virus-associated cancers has completed; the update covers the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Hodgkin Lymphoma
• Nasopharyngeal Carcinoma
• Non-hodgkin Lymphoma
• Squamous Cell Carcinoma of the Anus
• Squamous Cell Carcinoma of the Head and Neck
• Squamous Cell Carcinoma of the Penis
• Squamous Cell Carcinoma of the Vagina or Vulva

Drugs mentioned

• Avelumab (avelumab)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Cancer That is Associated With a Chronic Viral Infection, p16 Positive SCCHN | Phase 2 | Status: COMPLETED